dimethylphenylpiperazinium iodide has been researched along with Hirschsprung Disease in 2 studies
Dimethylphenylpiperazinium Iodide: A selective nicotinic cholinergic agonist used as a research tool. DMPP activates nicotinic receptors in autonomic ganglia but has little effect at the neuromuscular junction.
Hirschsprung Disease: Congenital MEGACOLON resulting from the absence of ganglion cells (aganglionosis) in a distal segment of the LARGE INTESTINE. The aganglionic segment is permanently contracted thus causing dilatation proximal to it. In most cases, the aganglionic segment is within the RECTUM and SIGMOID COLON.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wood, JD | 1 |
Brann, LR | 1 |
Hanani, M | 1 |
Lernau, OZ | 1 |
Zamir, O | 1 |
Nissan, S | 1 |
2 other studies available for dimethylphenylpiperazinium iodide and Hirschsprung Disease
Article | Year |
---|---|
Pharmacological analysis of rebound excitation in large intestine of piebald mouse model for Hirschsprung's disease.
Topics: Animals; Atropine; Dimethylphenylpiperazinium Iodide; Guanethidine; Hirschsprung Disease; Indomethac | 1986 |
Nerve mediated responses to drugs and electrical stimulation in aganglionic muscle segments in Hirschsprung's disease.
Topics: Child; Dimethylphenylpiperazinium Iodide; Electric Stimulation; Electrophysiology; Hirschsprung Dise | 1986 |